VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,329,066 | +1.7% | 307,655 | +55.2% | 0.00% | 0.0% |
| Q2 2023 | $1,306,742 | +1.0% | 198,292 | +4.1% | 0.00% | 0.0% |
| Q1 2023 | $1,293,445 | -9.6% | 190,492 | -1.6% | 0.00% | -33.3% |
| Q4 2022 | $1,431,115 | +4.3% | 193,655 | +39.5% | 0.00% | 0.0% |
| Q3 2022 | $1,372,000 | +170.6% | 138,847 | +198.5% | 0.00% | +200.0% |
| Q2 2022 | $507,000 | -63.7% | 46,518 | -62.3% | 0.00% | -66.7% |
| Q1 2022 | $1,396,000 | -29.9% | 123,478 | -2.7% | 0.00% | -25.0% |
| Q4 2021 | $1,991,000 | -39.4% | 126,912 | -33.8% | 0.00% | -42.9% |
| Q3 2021 | $3,286,000 | -23.5% | 191,770 | -4.3% | 0.01% | -30.0% |
| Q2 2021 | $4,296,000 | +79.6% | 200,418 | +23.9% | 0.01% | +66.7% |
| Q1 2021 | $2,392,000 | +16.9% | 161,794 | +2.5% | 0.01% | +20.0% |
| Q4 2020 | $2,046,000 | +56.5% | 157,822 | +14.4% | 0.01% | +25.0% |
| Q3 2020 | $1,307,000 | +3.3% | 137,913 | +24.4% | 0.00% | 0.0% |
| Q2 2020 | $1,265,000 | +10.4% | 110,880 | +0.3% | 0.00% | 0.0% |
| Q1 2020 | $1,146,000 | -66.1% | 110,598 | -46.3% | 0.00% | -60.0% |
| Q4 2019 | $3,381,000 | +30.5% | 206,055 | +5.6% | 0.01% | +42.9% |
| Q3 2019 | $2,591,000 | +1.8% | 195,124 | +8.1% | 0.01% | -12.5% |
| Q2 2019 | $2,544,000 | -19.4% | 180,520 | +5.0% | 0.01% | -27.3% |
| Q1 2019 | $3,158,000 | -18.9% | 171,892 | +4.0% | 0.01% | -21.4% |
| Q4 2018 | $3,894,000 | +26.4% | 165,327 | +23.2% | 0.01% | +27.3% |
| Q3 2018 | $3,080,000 | +80.5% | 134,196 | +49.9% | 0.01% | +83.3% |
| Q2 2018 | $1,706,000 | -61.6% | 89,510 | -66.1% | 0.01% | -64.7% |
| Q1 2018 | $4,448,000 | +5.6% | 263,959 | -4.7% | 0.02% | +13.3% |
| Q4 2017 | $4,212,000 | -12.1% | 277,088 | +3.5% | 0.02% | -11.8% |
| Q3 2017 | $4,792,000 | +17014.3% | 267,671 | +15516.7% | 0.02% | – |
| Q2 2017 | $28,000 | +115.4% | 1,714 | +81.2% | 0.00% | – |
| Q1 2017 | $13,000 | 0.0% | 946 | +15.9% | 0.00% | – |
| Q4 2016 | $13,000 | -95.9% | 816 | -97.1% | 0.00% | -100.0% |
| Q3 2015 | $319,000 | – | 28,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |